Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.
about
Interventions for preventing bone disease in kidney transplant recipientsBisphosphonates: mechanism of action and role in clinical practiceEfficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-AnalysisMineral and bone disorder after kidney transplantationManagement of mineral and bone disorder after kidney transplantation.Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation.Skeletal effects of zoledronic acid in an animal model of chronic kidney diseaseTemporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United StatesPrevention of fractures after solid organ transplantation: a meta-analysis.Reduced fracture risk with early corticosteroid withdrawal after kidney transplant.Vitamin D in organ transplantationClinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials.Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation.Updated recommendations for the diagnosis and management of osteoporosis: a local perspectiveLong-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantationPotential future uses of calcimimetics in patients with chronic kidney disease.Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medicationsMicro-MR imaging-based computational biomechanics demonstrates reduction in cortical and trabecular bone strength after renal transplantationEffect of a convenient single 90-mg pamidronate dose on biochemical markers of bone metabolism in patients with acute spinal cord injury.Effect of risedronate on bone in renal transplant recipients.Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone qualityAtypical Parathyroid Adenoma Complicated with Protracted Hungry Bone Syndrome after Surgery: A Case Report and Literature Review.Effect of kidney transplantation on bone.Bisphosphonates and bone fractures in long-term kidney transplant recipientsEvaluation of nutrient intake in early post kidney transplant recipientsZoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.Skeletal integrity and visceral transplantationPrevalence of Hypercalcaemia in a Renal Transplant Population: A Single Centre Study.Metabolic bone diseases in kidney transplant recipients.Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment.Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients.Post-transplantation osteoporosis.Therapeutic management of post-kidney transplant hyperparathyroidism.Can bisphosphonates play a role in the treatment of children with chronic kidney disease?Osteoporosis after transplantation.Long-term management of the kidney transplant recipient.Bone disease in organ transplant patients: pathogenesis and management.The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation.Renale osteodystrophie.Bone and mineral disorders after kidney transplantation: therapeutic strategies
P2860
Q24243851-D122D829-1A1E-407D-960A-5FFA3664625EQ24644708-C86B5E3F-E430-4CA2-AF93-86E8A7AD6842Q26769030-658C7342-22CC-4336-92D5-273175AF1ED6Q26771398-61B7C28A-383A-46A8-88E0-67C26F57F742Q30418461-4066C645-D607-46EF-AFFB-A3C978670503Q33571316-FD71D7D6-45EC-4266-BE0A-F934D0C0C04EQ33779709-221328A2-B74D-4820-A12C-E63D09CC7146Q33983422-50CCE3CC-25A9-4AB2-B93A-3D718C900446Q33995388-923DE9C9-87F3-4300-B0F3-BB8E96ED3AB7Q34069674-6F608F2A-6C9C-4523-B0F0-15716D8B9426Q34069825-99728968-8D22-4492-8480-74D12FEEEB21Q34269100-D8483780-7A01-41C7-AD72-97B92EB9A953Q34590956-B8EC9EF3-01BB-4194-BD16-5E5B23829A2BQ35008617-57C82C2F-2660-4624-B081-B536926939ADQ35226929-CCC5AB02-98CC-405D-8A8A-886068A6B7CAQ35573650-BA6499C1-76F3-4966-B338-56FBD2973B4EQ35740351-7CAAF4F8-D608-4C6D-AC66-75A339D2EC2EQ35773561-96042111-3B31-4C03-BBA9-E3EB900569D1Q35781312-8F5DD35A-1913-417B-B924-3378B8920518Q36109164-E7BBFE3F-2014-47B4-82A5-16F012DE0ACCQ36199520-2B736950-CB23-42E3-B59E-90D0614ADD71Q36320286-AF5476D8-2422-408D-8943-C70E08822146Q36554790-1E1B2D78-5649-4A8C-9E3C-1B02C6274D6EQ36606360-157060F2-25F2-40E1-ACE8-E0AD1420CDDCQ36611054-D39C1411-FE7D-4F49-8AC1-78A243B75924Q36666432-3F78EBDE-4A4E-49EF-BEE6-9D57F029D3A5Q36908631-2F1DFC5B-ED79-4F9E-BDF2-45F22F39369BQ37132254-A0C3510B-A1AA-4DFC-8D01-25BF2BCFA16DQ37195397-710BFDB6-2AB8-400B-A5C5-AE36BCB5414BQ37522423-E4C08C67-A091-49D3-BC60-42C81D2D85B9Q37622392-B575BAFE-0302-4FFB-9CD3-55C433914320Q37756580-194CB403-A0EB-415B-8840-7E688426FE0CQ37767247-77050287-5BF1-4672-A009-7CB3D7801003Q37832414-1C687CF1-7B8D-436A-99D8-7E446EE66ED0Q37968224-61A344D5-9BAF-4196-8B87-7DA968878C3FQ37978101-EA91C249-B5EC-4649-A523-054926386CF5Q38018212-9F808AF5-0BA7-44E3-BD21-2CDB22DEF63BQ38043510-1D7CACA8-17C7-452E-A99B-59E55C17BC92Q38105272-0B3C7499-BAF8-4A11-8F10-3855748FF29EQ38181757-7444AB3C-4525-4121-AA3D-C5CD8402E6E4
P2860
Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Prevention of bone loss in ren ...... al of intravenous pamidronate.
@en
Prevention of bone loss in ren ...... al of intravenous pamidronate.
@nl
type
label
Prevention of bone loss in ren ...... al of intravenous pamidronate.
@en
Prevention of bone loss in ren ...... al of intravenous pamidronate.
@nl
prefLabel
Prevention of bone loss in ren ...... al of intravenous pamidronate.
@en
Prevention of bone loss in ren ...... al of intravenous pamidronate.
@nl
P2093
P1476
Prevention of bone loss in ren ...... al of intravenous pamidronate.
@en
P2093
Daniel Glicklich
Guodong Wang
Hartmut Malluche
Istvan Bognar
Katherine Figueroa
Larry Burris
Maria Coco
Marie Claude Faugere
Patricia McDonough
Peter Durkin
P304
P356
10.1097/01.ASN.0000087092.53894.80
P577
2003-10-01T00:00:00Z